David George Standaert MD PhD
Movement Disorder
Professor and Chairman of Neurology at University of Alabama at Birmingham
Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Standaert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Professor and Chair of Neurology
Education & Training
Massachusetts General Hospital1992 - 1995
University of Pennsylvania Health SystemResidency, Neurology, 1989 - 1992
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1988 - 1989- Washington University in St. Louis School of MedicineClass of 1988
Harvard UniversityAB, Biochemistry , Magma cum laude, 1978 - 1982
Certifications & Licensure
AL State Medical License 2006 - 2025
MA State Medical License 1992 - 2025
PA State Medical License 1990 - 1992
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Best Doctor Best Doctors in America, 2009-2019
- Regional Top Doctor Castle Connolly, 2017
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Connectomic-guided stereotactic radiosurgery thalamotomy for tremor: a patient-specific approach to enhance outcomes.Erik H Middlebrooks, Vishal Patel, Richard A Popple, Harrison C Walker, Evan M Thomas
Journal of Neurosurgery. 2025-02-14 - Alpha synuclein overexpression can drive microbiome dysbiosis in mice.Timothy R Sampson, Zachary D Wallen, Woong-Jai Won, David G Standaert, Haydeh Payami
Scientific Reports. 2025-02-01 - Toward a biological definition of neuronal and glial synucleinopathies.Claudio Soto, Brit Mollenhauer, Oskar Hansson, Un Jung Kang, Roy N Alcalay
Nature Medicine. 2025-02-01
Press Mentions
Ozempic-Type Drug Fails to Slow Parkinson’s, Study FindsFebruary 5th, 2025- Relative of Ozempic Failed to Treat Parkinson’s Disease in TrialFebruary 4th, 2025
- UAB Announces Key Health System, Heersink School of Medicine LeadersFebruary 3rd, 2023
- Join now to see all
Grant Support
- Innate and Adaptive Immunity in Parkinson DiseaseUNIVERSITY OF ALABAMA AT BIRMINGHAM2018–2025
- Brain Regions And Genes Implicated In Early Onset DystoniaNational Institute Of Neurological Disorders And Stroke2009–2011
- Torsina And The Pathophysiology Of DystoniaNational Institute Of Neurological Disorders And Stroke2008
- Abnormalities In Gene Expression And SynucleinopathiesNational Institute Of Neurological Disorders And Stroke2004–2008
- Torsina And The Pathophysiology Of DystoniaNational Institute Of Neurological Disorders And Stroke2004–2007
- NMDA Receptors--Regulation Of Basal Ganglia FunctionNational Institute Of Neurological Disorders And Stroke2001–2004
- Agonist Pramipexole VS Levodopa On Motor Complications In Parkinson'S DiseaseNational Center For Research Resources1997–2002
- NMDA Receptors--Regulation Of Basal Ganglia FunctionNational Institute Of Neurological Disorders And Stroke1996–2000
Professional Memberships
- Fellow
- American Neurological AssociationFellow
- Movement Disorders SocietyMember
- Society for NeuroscienceMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
